Brief: Pherecydes Pharma Granted First Patent In China
16/12/2021 06:43
Dec 16 (Reuters) - PHERECYDES PHARMA SA ALPHE.PA :
* PHERECYDES PHARMA CONTINUES TO STRENGTHEN ITS INTELLECTUAL
PROPERTY WITH A FIRST PATENT GRANTED IN CHINA, FOR ITS
ANTI-STAPHYLOCOCCUS AUREUS PHAGES
* TODAY ANNOUNCES GRANTING OF A PATENT FOR ITS
ANTI-STAPHYLOCOCCUS
AUREUS PHAGES BY CHINESE PATENT OFFICE
* FIRST PATENT GRANTED IN CHINA FOR PHERECYDES PHARMA'S
PHAGES AND
SECOND PATENT GRANTED FOR THIS FAMILY OF PHAGES AFTER ONE
RECENTLY OBTAINED IN ISRAEL
Source text for Eikon: ID:nBwPxTVqa
Further company coverage: ALPHE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Pherecydes Pharma SA
See all newsBrief: Erytech And Pherecydes Announce Merger And Name Change To Phaxiam Therapeutics
Brief: Pherecydes Pharma SA - Pherecydes Pharma And Erytech Pharma Shareholders Approve Merger Between Two Companies To Create Phaxiam Therapeutics
Brief: Erytech Announces That The Commercial Court Has Rejected Akkadian's Request To Postpone The Vote On The Merger With Pherecydes Pharma
Brief: Erytech: urges shareholders to vote for merger with Pherecydes and dismisses Akkadian's moves
Brief: Erytech Pharma Says Akkadian Has Initiated Proceedings To Postpone Vote On Merger With Pherecydes